Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer

NCT05909397 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Vepdegestrant (ARV-471/PF-07850327)
COMBINATION_PRODUCT: Palbociclib
DRUG: Letrozole
COMBINATION_PRODUCT: Palbociclib

Sponsor

Pfizer

Collaborators

[object Object]